Today

Agents

Chat

Arena

Discover

More

App

Spyre Therapeutics: Wedbush cuts target price to $120 from $123

SYRE•2026-11-04

Wedbush cut its target price for Spyre Therapeutics to $120 from $123.

Related News

A

Bernstein raises Apple target price to $380 from $370

AAPL•2026-11-04

Cenovus climbs after record output drives Q3 earnings

CVE•2026-11-04

Mirum Pharmaceuticals: Raymond James raises target price to $189 from $183

MIRM•2026-11-04

Bernstein cuts CleanSpark target price to $11 from $24

CLSK•2026-11-04

Navitas gains on upbeat forecast, Q3 revenue beat

NVTS•2026-11-04

Spyre Therapeutics: Wedbush cuts target price to $120 from $123 - SYRE News | Rallies